Form 8-K BIOGEN INC. For: Apr 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
Biogen expects $34 million charge in first quarter 2026
April 6, 2026 6:36 AM EDTBiogen Inc. (NASDAQ: BIIB) announced it expects to record approximately $34 million in acquired in-process research and development, upfront and milestone expenses on a pre-tax basis during the first quarter of 2026.
The charge is projected to impact both GAAP and non-GAAP net income per... More
